About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Child-Friendly Ringworm Drug

by Ann Samuel on September 29, 2007 at 5:39 PM
FDA Approves Child-Friendly Ringworm Drug

Help is at hand for children who have ringworm infection and who refuse to pop a pill.

The Food and Drug Administration has recently approved a new version of a ringworm drug that is designed for children four years old and up. It can easily be slipped into the meals of tiny tots with a bit of help from their parents.

Advertisement

The medication, manufactured by Novartis, comes in crumb-size granules. It is specifically approved to treat tinea capitis or ringworm, a scalp fungus that typically affects children. Ringworm can cause severe itching, dandruff and bald patches. It is a persistent and contagious fungal infection that usually does not respond to topical treatment.

"A parent's ability to sprinkle it on the food of a child, who may not like to take medicine, should go a long way to helping ensure the infection is properly treated , as well as to limit its spread," Steven Galson, director of FDA's drug center was quoted.
Advertisement

FDA had requested Novartis to develop a version of Lamisil known generically as terbinafine hydrochloride, which is palatable to children.

Under federal law, FDA can award exclusive marketing rights to companies that develop drugs especially for use in children.

Source: Medindia
ANN/C
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

WHO Approves R21/Matrix-M, the World's Second Malaria Vaccine
R21/Matrix-M, the world's second malaria vaccine is readily deployable, and cost-effective making it prepared for distribution in areas where it is most essential.
New Inverse Vaccine Sparks Hope in Diabetes, Arthritis, and Crohn's Disease
The reverse vaccine uses the liver's natural "non-target" signals to prevent autoimmune responses against naturally decaying cells.
Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

FDA Approves Child-Friendly Ringworm Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests